Also upregulated is the oncogenic miR-22 that triggers EMT, inhibits the ten-eleven-translocation gene 2 (TET2) tumor suppressors, causing an enhanced hematopoietic stem cell self-renewal, transformation and metastasis [28,29]. Here, TET2 is linked to neoplasm.